WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 157 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $51,000 | – | 1,450 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coupland Cardiff Asset Management LLP | 1,055,000 | $40,491,000 | 27.81% |
| DELTA PARTNERS LP | 309,732 | $11,888,000 | 13.39% |
| Black Creek Investment Management Inc. | 2,457,034 | $94,301,000 | 11.10% |
| Consonance Capital Management LP | 1,252,314 | $48,064,000 | 7.88% |
| Sloane Robinson LLP | 247,700 | $9,507,000 | 5.56% |
| GRATRY & Co LLC | 205,800 | $7,899,000 | 2.59% |
| Grandeur Peak Global Advisors, LLC | 230,385 | $8,842,000 | 2.36% |
| Mirae Asset Global Investments Co., Ltd. | 1,130,882 | $43,403,000 | 1.82% |
| Integre Asset Management, LLC | 200,173 | $7,683,000 | 1.74% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 90,560 | $3,476,000 | 1.64% |